Bevacizumab added to neoadjuvant chemotherapy for breast cancer

Harry D. Bear, Gong Tang, Priya Rastogi, Charles E. Geyer, Andre Robidoux, James N. Atkins, Luis Baez-Diaz, Adam M. Brufsky, Rita S. Mehta, Louis Fehrenbacher, James A. Young, Francis M. Senecal, Rakesh Gaur, Richard G. Margolese, Paul T. Adams, Howard M. Gross, Joseph P. Costantino, Sandra M. Swain, Eleftherios P. Mamounas, Normal Wolmark

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)201-202
Number of pages2
JournalObstetrical and Gynecological Survey
Volume68
Issue number3
DOIs
StatePublished - Mar 1 2013

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Bear, H. D., Tang, G., Rastogi, P., Geyer, C. E., Robidoux, A., Atkins, J. N., Baez-Diaz, L., Brufsky, A. M., Mehta, R. S., Fehrenbacher, L., Young, J. A., Senecal, F. M., Gaur, R., Margolese, R. G., Adams, P. T., Gross, H. M., Costantino, J. P., Swain, S. M., Mamounas, E. P., & Wolmark, N. (2013). Bevacizumab added to neoadjuvant chemotherapy for breast cancer. Obstetrical and Gynecological Survey, 68(3), 201-202. https://doi.org/10.1097/OGX.0b013e3182877729